CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) Major Shareholder Stuart M. Sloan Sells 532,486 Shares

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) major shareholder Stuart M. Sloan sold 532,486 shares of the stock in a transaction dated Wednesday, September 25th. The shares were sold at an average price of $0.10, for a total value of $53,248.60. Following the transaction, the insider now owns 21,067,956 shares in the company, valued at $2,106,795.60. This trade represents a 2.47 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

CERo Therapeutics Stock Performance

NASDAQ CERO opened at $0.22 on Friday. The company has a 50-day simple moving average of $0.12 and a two-hundred day simple moving average of $0.32. CERo Therapeutics Holdings, Inc. has a 12-month low of $0.06 and a 12-month high of $12.80.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.